Skip to main content

Table 3 Magnitude of the pharmacological interaction between BDP and FF administered at 100:6 combination-ratio in non-sensitized and passively sensitized human medium and small airways (PCLS)

From: Beclomethasone dipropionate and formoterol fumarate synergistically interact in hyperresponsive medium bronchi and small airways

 

Medium bronchi

Small airways

Non-sensitized

Passively sensitized

Non-sensitized

Passively sensitized

Relaxant effect (% Emax)

Combination Index

Interaction magnitude

Combination Index

Interaction magnitude

Combination Index

Interaction magnitude

Combination Index

Interaction magnitude

15

0.47

+++

0.51

+++

0.47

+++

0.06

+++++

25

0.34

+++

0.38

+++

0.29

++++

0.08

+++++

50

0.22

++++

0.26

++++

0.12

++++

0.15

++++

75

0.15

++++

0.20

++++

0.05

+++++

0.28

++++

90

0.10

++++

0.14

++++

0.02

+++++

0.52

+++

  1. The smaller the Combination Index, the greater the synergistic interaction. +++: synergism; ++++: strong synergism; +++++: very strong synergism. BDP Beclomethasone dipropionate, FF formoterol fumarate, PCLS Precision cut lung slices